By Marie-Claude Bergouignan, Matthieu Montalban, Andy Smith and Erdem Sakinç
With its significant economic weight, pharmaceutical industry is confronted today with many difficulties. Increasing market share of generic drugs, even more restrictive regulations which limit market authorization or ongoing development of biotechnologies are only some of the challenges to face for an industry which downsizes today an important part of its workforce. This study proposes an overview of pharmaceutical industry, essentially the French one, from the angle of the globalization of the economies and the regulation of the market for pharmaceuticals.
Click HERE to find more information about this book at La Documentation française.